-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
SARS-CoV-2 virus infection caused by COVID-19 disease (commonly known as the new crown) will cause obvious respiratory complications, and it is the main cause of morbidity and mortality.
SARS-CoV-2 virus infection caused by COVID-19 disease (commonly known as the new crown) will cause obvious respiratory complications, and it is the main cause of morbidity and mortality.
The researchers designed a prospective international multicenter cohort study that included consecutive patients who were treated with AP.
The results showed that from March 1, 2020 to July 23, 2020, a total of 1,777 AP patients were enrolled.
Therefore, this study concluded that patients with AP combined with SARS-CoV-2 infection have a significantly increased risk of severe AP, worse clinical outcomes, longer hospital stays, and higher 30-day mortality.
Therefore, this study concluded that patients with AP combined with SARS-CoV-2 infection have a significantly increased risk of severe AP, worse clinical outcomes, longer hospital stays, and higher 30-day mortality.
Original source:
Sanjay Pandanaboyana.
bmj.
com/content/early/2021/03/03/gutjnl-2020-323364" target="_blank" rel="noopener">SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study.
Leave a message here